Home › Liposarcoma › California › Los Angeles
Liposarcoma clinical trials in Los Angeles, CA
3 studies for Liposarcoma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
RecruitingPhase 3
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- and 1 more
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
RecruitingPhase 2
- Ellison Institute, Los Angeles
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RecruitingPhase 1
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Liposarcoma trials in other cities
- Houston, TX11 studies
- New York City, NY7 studies
- Boston, MA7 studies
- St. Louis, MO5 studies
- Queens, NY5 studies
- Chicago, IL5 studies
- Nashville, TN4 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Atlanta, GA4 studies
- Edison, NJ4 studies
- Seattle, WA4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer92 studies
- Breast Cancer73 studies
- Cancer (all types)73 studies
- Prostate Cancer64 studies
- Colorectal Cancer61 studies
- Metastatic Cancer57 studies
- Ovarian Cancer53 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma43 studies
- Pancreatic Cancer36 studies
- Endometrial Cancer35 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.